NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clearside Biomedical,
Inc. (NASDAQ:CLSD), JELD-WEN Holding, Inc. (NYSE:JELD), L.B. Foster Company (NASDAQ:FSTR), Merrimack Pharmaceuticals, Inc.
(NASDAQ:MACK), Everi Holdings Inc. (NYSE:EVRI), and Drive Shack Inc. (NYSE:DS), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CLSD DOWNLOAD: http://Fundamental-Markets.com/register/?so=CLSD
JELD DOWNLOAD: http://Fundamental-Markets.com/register/?so=JELD
FSTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=FSTR
MACK DOWNLOAD: http://Fundamental-Markets.com/register/?so=MACK
EVRI DOWNLOAD: http://Fundamental-Markets.com/register/?so=EVRI
DS DOWNLOAD: http://Fundamental-Markets.com/register/?so=DS
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Clearside Biomedical, Inc. (NASDAQ:CLSD), JELD-WEN Holding, Inc. (NYSE:JELD), L.B. Foster Company (NASDAQ:FSTR), Merrimack
Pharmaceuticals, Inc. (NASDAQ:MACK), Everi Holdings Inc. (NYSE:EVRI), and Drive Shack Inc. (NYSE:DS) on a fundamental level and
outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's
readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed October 12th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CLEARSIDE BIOMEDICAL, INC. (CLSD) REPORT OVERVIEW
Clearside Biomedical's Recent Financial Performance
For the twelve months ended December 31st, 2017 vs December 31st, 2016, Clearside Biomedical reported revenue of
$0.35MM vs $0.52MM (down 33.65%) and analysts estimated basic earnings per share -$2.33 vs -$1.97. Analysts expect earnings to be
released on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the
same quarter last year was -$0.72. The estimated EPS forecast for the next fiscal year is -$2.19 and is expected to report on March
13th, 2019.
To read the full Clearside Biomedical, Inc. (CLSD) report, download it here: http://Fundamental-Markets.com/register/?so=CLSD
-----------------------------------------
JELD-WEN HOLDING, INC. (JELD) REPORT OVERVIEW
JELD-WEN Holding's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, JELD-WEN Holding reported revenue of $1,172.50MM
vs $948.79MM (up 23.58%) and analysts estimated basic earnings per share $0.34 vs $0.45 (down 24.44%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, JELD-WEN Holding reported revenue of $3,763.93MM vs $3,666.80MM (up 2.65%) and analysts
estimated basic earnings per share $0.00 vs -$1.08. Analysts expect earnings to be released on November 6th, 2018. The report will
be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.55. The estimated EPS
forecast for the next fiscal year is $2.29 and is expected to report on February 20th, 2019.
To read the full JELD-WEN Holding, Inc. (JELD) report, download it here: http://Fundamental-Markets.com/register/?so=JELD
-----------------------------------------
L.B. FOSTER COMPANY (FSTR) REPORT OVERVIEW
L.B. Foster's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, L.B. Foster reported revenue of $172.89MM vs
$144.86MM (up 19.35%) and analysts estimated basic earnings per share $0.48 vs $0.29 (up 65.52%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, L.B. Foster reported revenue of $536.38MM vs $483.51MM (up 10.93%) and analysts
estimated basic earnings per share $0.40 vs -$13.79. Analysts expect earnings to be released on November 6th, 2018. The report will
be for the fiscal period ending September 30th, 2018.
To read the full L.B. Foster Company (FSTR) report, download it here: http://Fundamental-Markets.com/register/?so=FSTR
-----------------------------------------
MERRIMACK PHARMACEUTICALS, INC. (MACK) REPORT OVERVIEW
Merrimack Pharmaceuticals' Recent Financial Performance
Analysts expect earnings to be released on November 14th, 2018. The report will be for the fiscal period ending
September 30th, 2018. The reported EPS for the same quarter last year was -$0.40. The estimated EPS forecast for the next fiscal
year is -$3.92 and is expected to report on March 11th, 2019.
To read the full Merrimack Pharmaceuticals, Inc. (MACK) report, download it here: http://Fundamental-Markets.com/register/?so=MACK
-----------------------------------------
EVERI HOLDINGS INC. (EVRI) REPORT OVERVIEW
Everi's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Everi reported revenue of $118.68MM vs $242.23MM
(down 51.00%) and analysts estimated basic earnings per share $0.02 vs -$0.29. For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Everi reported revenue of $974.95MM vs $859.46MM (up 13.44%) and analysts estimated basic earnings per share
-$0.78 vs -$3.78. Analysts expect earnings to be released on October 29th, 2018. The report will be for the fiscal period ending
September 30th, 2018. The reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal
year is $0.08 and is expected to report on March 12th, 2019.
To read the full Everi Holdings Inc. (EVRI) report, download it here: http://Fundamental-Markets.com/register/?so=EVRI
-----------------------------------------
DRIVE SHACK INC. (DS) REPORT OVERVIEW
Drive Shack's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Drive Shack reported revenue of $91.00MM vs
$81.36MM (up 11.85%) and analysts estimated basic earnings per share -$0.09 vs -$0.09. For the twelve months ended December 31st,
2017 vs December 31st, 2016, Drive Shack reported revenue of $292.59MM vs $298.88MM (down 2.10%) and analysts estimated basic
earnings per share -$0.71 vs $1.07. Analysts expect earnings to be released on November 7th, 2018. The report will be for the
fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast
for the next fiscal year is -$0.40 and is expected to report on March 6th, 2019.
To read the full Drive Shack Inc. (DS) report, download it here: http://Fundamental-Markets.com/register/?so=DS
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
